Related Experiment Video
Updated: Sep 2, 2025

Establishment and Validation of a Rat Model of Pulmonary Arterial Hypertension Associated with Pulmonary Fibrosis
Published on: May 23, 2025
Silencing TUFM Inhibits Development of Monocrotaline-Induced Pulmonary Hypertension by Regulating Mitochondrial
Ruyuan Wei1, Xin Lv1, Changcun Fang1,2
1Cheeloo College of Medicine, Shandong University, Jinan City, Shandong Province, 250012, China.
Abstract:
Pulmonary arterial hypertension (PAH) is an extremely malignant cardiovascular disease which mainly involves the uncontrollable proliferation of the pulmonary arterial smooth muscular cells (PASMCs). Recent studies have confirmed that mitochondria play an important role in the pathogenesis of pulmonary hypertension through sensing cell hypoxia, energy metabolism conversion, and apoptosis. As a mitochondrial membrane protein, TUFM has been regarded to be related to mitochondrial autophagy (mitophagy), apoptosis, and oxidative stress. Considering these factors are closely associated with the pathogenesis of PAH, we hypothesize that TUFM might play a role in the development of PAH. Our preliminary examination has showed TUFM mainly expressed in the PASMCs, and the subsequent test indicated an increased TUFM expression in the SMCs of pulmonary arteriole in monocrotaline- (MCT-) induced PAH rat model compared with the normal rat. The TUFM knockdown (Sh-TUFM) or overexpressed (OE-TUFM) rats were used to establish PAH by treating with MCT. A notable lower pulmonary arterial systolic pressure together with slightly morphological changes of pulmonary arteriole was observed in the Sh-TUFM group compared with the single MCT-induced PAH group. Increased levels of P62 and Bax and reduced LC3II/I, BECN1, and Bcl2 were detected in the Sh-TUFM group, while the expressions of these proteins in the OE-TUFM group were contrast to the results of the Sh-TUFM group. To elucidate the possible mechanism underlying biological effect of TUFM in PAH, PASMCs were treated with silence or overexpression of TUFM and then exposed to hypoxia condition. An obviously high levels of P62 and Bax along with a decreased LC3 II/I, BECN1, ULK1, Atg12, Atg13, and Bcl2 levels were noticed in cells with silence of TUFM. Moreover, the phosphorylated AMPK and mTOR which was well known in mitophagy modulating vary by the alternation of TUFM. These observations suggested that TUFM silence inhibits the development of MCT-induced PAH via AMPK/mTOR pathway.
Insights
TUFM protein knockdown mitigates pulmonary arterial hypertension (PAH) by inhibiting PASMC proliferation and regulating mitophagy via the AMPK/mTOR pathway. This suggests TUFM as a potential therapeutic target for PAH.
Area of Science:
- Cardiovascular Biology
- Mitochondrial Medicine
- Cellular Pathophysiology
Background:
- Pulmonary arterial hypertension (PAH) is a severe cardiovascular disease driven by pulmonary arterial smooth muscle cell (PASMC) proliferation.
- Mitochondria are crucial in PAH pathogenesis, influencing hypoxia sensing, energy metabolism, and apoptosis.
- TUFM, a mitochondrial protein, is implicated in mitophagy, apoptosis, and oxidative stress, processes relevant to PAH.
Purpose of the Study:
- To investigate the role of TUFM in the development of pulmonary arterial hypertension (PAH).
- To explore the underlying molecular mechanisms by which TUFM influences PAH pathogenesis, particularly concerning mitophagy and cell signaling pathways.
Main Methods:
- TUFM expression was analyzed in monocrotaline (MCT)-induced PAH rat models and PASMCs.
- TUFM knockdown (Sh-TUFM) and overexpression (OE-TUFM) models were established in rats and PASMCs.
- Hemodynamic and morphological changes, protein levels (P62, Bax, LC3II/I, BECN1, Bcl2), and AMPK/mTOR signaling were assessed under normoxic and hypoxic conditions.
Main Results:
- TUFM expression was elevated in PASMCs of MCT-induced PAH rats.
- TUFM knockdown in rats significantly reduced pulmonary arterial pressure and altered arteriolar morphology compared to PAH controls.
- TUFM modulation affected key proteins involved in mitophagy and apoptosis, with knockdown promoting mitophagy and inhibiting PASMC proliferation, while overexpression had opposing effects. AMPK/mTOR pathway phosphorylation was altered by TUFM levels.
Conclusions:
- TUFM plays a significant role in the pathogenesis of MCT-induced pulmonary arterial hypertension.
- TUFM knockdown inhibits PAH development, likely by promoting mitophagy and modulating the AMPK/mTOR signaling pathway.
- Targeting TUFM may offer a novel therapeutic strategy for treating pulmonary arterial hypertension.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
TGF - β Signaling Pathway
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

